Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Schizophrenia Clinical Trial

Official title:

Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00400166
• Other study ID #: 0607001641
• Status: Completed
• Phase: N/A
• First received: November 15, 2006
• Last updated: June 10, 2009
• Start date: December 2006
• Est. completion date: May 2009

Study information

• Verified date: June 2009
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.

Description:

The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.

Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 71
• Est. completion date: May 2009
• Est. primary completion date: May 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• 18 years of age or older

• Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)

• A history of two or more prior admissions within the past 18 months

• Proficient in the use of the English language

• A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features

Exclusion Criteria:

• Inability to give signed, written consent

• Primary DSM-IV diagnosis of substance abuse/dependence

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Bipolar Disorder
• Disease
• Psychotic Depression
• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Intervention

Behavioral:
• Recovery Mentor
Provided Recovery Mentor services

Locations

Country	Name	City	State
United States	Yale-New Haven Psychiatric Hospital	New Haven	Connecticut

Sponsors (3)

Lead Sponsor	Collaborator
Yale University	Connecticut State, Department of Mental Health and Addiction Services, Eli Lilly and Company

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of hospitalizations		9 months	No
Secondary	Sense of community		Baseline, 3 and 9 months	No
Secondary	Motivation for change		Baseline, 3 and 9 months	No
Secondary	Social functioning		Baseline, 3 abd 9 months	No
Secondary	Hope		Baseline, 3 and 9 months	No
Secondary	Self-determination		Baseline, 3 and 9 months	No
Secondary	Functional status		Baseline, 3 and 9 months	No
Secondary	Treatment relationship		Baseline, 3 and 9 months	No

External Links

•   Yale Program for Recovery and Community Health